Denis L. Jardim

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant, Martin Schüler, Gopa Iyer et al. · The Lancet Oncology · 2023 · 175 citations · Full text

Fgfr Alterations, Medicine, Pathology +7

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

Denis L. Jardim, Jennifer J. Wheler, Kenneth R. Hess et al. · PLoS ONE · 2014 · 103 citations · Full text

Analysis of 1,115 Patients Tested for <i>MET</i> Amplification and Therapy Response in the MD Anderson Phase I Clinic

Denis L. Jardim, Chad Tang, Débora De Melo Gagliato et al. · Clinical Cancer Research · 2014 · 78 citations · Full text

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

Sherri Z. Millis, Denis L. Jardim, Lee A. Albacker et al. · Cancer · 2018 · 54 citations · Full text

Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

Denis L. Jardim, Anthony P. Conley, Vivek Subbiah · Orphanet Journal of Rare Diseases · 2013 · 46 citations · Full text